Status:
COMPLETED
DCP3 Based Multi-component Intervention for Hypertension Management and Control
Lead Sponsor:
Health Services Academy, Islamabad, Pakistan
Conditions:
Hypertension
Hypertensive Patients
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study aims to enable delivery of a multi-component intervention comprising of strategies based on Disease Control Priorities 3rd edition for management of hypertension among hypertensive patients...
Eligibility Criteria
Inclusion
- • Pakistani nationals both male and female of age 18 years and above will be invited to participate in the study
- Similarly; known hypertensive patients having a systolic blood pressure of ≥140 mmHg on current treatment will be included \&
- Patients with co-morbidities will also be included such as those suffering from cardiac ailments (angina or transient ischemic attack (TIA) and diabetes
Exclusion
- • Patients with compromised neurological or cognitive state who are unable to provide their consent will be excluded
- Patients suffering from non-cardiovascular diseases and life-threatening illnesses such as angiographically proven coronary disease, peripheral or cerebral vascular disease, pulmonary hypertension, having history of myocardial infarction, stroke/PCI/stent or high-risk conditions will be excluded from participation
- Patients with chronic conditions and co-morbidities requiring surgical intervention or treatment such as cardiomyopathies or congenital abnormalities \&
- Patients receiving dialysis will also be excluded from the study
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04336631
Start Date
November 1 2019
End Date
March 30 2020
Last Update
April 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Armed Forces Institute of Cardiology (AFIC/NIHD)
Rawalpindi, <Select>, Pakistan, 74200